These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21598346)

  • 21. Stenting unprotected left main: the outcome is not always favorable.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):539-40. PubMed ID: 18307235
    [No Abstract]   [Full Text] [Related]  

  • 22. The AUTAX (Austrian Multivessel TAXUS-Stent) registry: another useful registry on stented angioplasty for multivessel disease?
    Wijns W
    JACC Cardiovasc Interv; 2009 Aug; 2(8):728-30. PubMed ID: 19695540
    [No Abstract]   [Full Text] [Related]  

  • 23. Time for coronary artery bypass grafting to make a comeback?
    Taggart D
    Semin Thorac Cardiovasc Surg; 2011; 23(1):5-7. PubMed ID: 21807289
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of single- versus two-stent techniques in treatment of unprotected left main coronary bifurcation disease.
    Kim WJ; Kim YH; Park DW; Yun SC; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2011 May; 77(6):775-82. PubMed ID: 21520380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left anterior descending coronary artery revascularization patient-tailored therapy?
    Abbate A; Vetrovec GW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):492-3. PubMed ID: 19463350
    [No Abstract]   [Full Text] [Related]  

  • 26. The value of clinical wisdom in randomised studies, real-world registries and new hypotheses.
    Bernardi G; Morocutti G; Spedicato L; Zanuttini D
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):313-7. PubMed ID: 17443094
    [No Abstract]   [Full Text] [Related]  

  • 27. Provisional side-branch stenting in distal left main lesions: one-size-may-not-fit-all.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 May; 77(6):773-4. PubMed ID: 21520379
    [No Abstract]   [Full Text] [Related]  

  • 28. The Holy Grail for DES: does efficacy translate into real world effectiveness?
    Hillegass WB
    Catheter Cardiovasc Interv; 2010 Sep; 76(3):381-2. PubMed ID: 20839352
    [No Abstract]   [Full Text] [Related]  

  • 29. Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: identifying patients who would benefit with CABG and understanding the potential mechanisms involved.
    Greason KL; Schaff HV
    Coron Artery Dis; 2010 Nov; 21(7):402-6. PubMed ID: 20706113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additional data supporting the safety and effectiveness of unprotected left main interventions.
    Shannon J; Colombo A
    EuroIntervention; 2011 Oct; 7(6):653-7. PubMed ID: 21986323
    [No Abstract]   [Full Text] [Related]  

  • 31. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
    [No Abstract]   [Full Text] [Related]  

  • 32. Complexity of atherosclerotic coronary artery disease and long-term outcomes in patients with unprotected left main disease treated with drug-eluting stents or coronary artery bypass grafting.
    Park DW; Kim YH; Yun SC; Song HG; Ahn JM; Oh JH; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    J Am Coll Cardiol; 2011 May; 57(21):2152-9. PubMed ID: 21596230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes and drug-eluting stents: what you get and what you don't.
    Marso SP
    JACC Cardiovasc Interv; 2008 Apr; 1(2):148-9. PubMed ID: 19463292
    [No Abstract]   [Full Text] [Related]  

  • 34. Optimizing the impact of primary percutaneous coronary intervention in acute myocardial infarction.
    Satler LF
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):201. PubMed ID: 21290554
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term outcomes after coronary bare-metal-stent and drug-eluting-stent implantations: a 'real-world' comparison among patients with diabetes with diffuse small vessel coronary artery disease.
    Koh AS; Chia S; Choi LM; Sim LL; Chua TS; Koh TH; Tan JW
    Coron Artery Dis; 2011 Mar; 22(1):96-9. PubMed ID: 21164343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug eluting stents in CTOs: why not?
    Vetrovec GW
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):333-4. PubMed ID: 21328678
    [No Abstract]   [Full Text] [Related]  

  • 37. Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease.
    Park SJ
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):13-4. PubMed ID: 21181967
    [No Abstract]   [Full Text] [Related]  

  • 38. Toward better stratification of patients with left main disease: value of clinical and angiographic-derived risk scores.
    Applegate RJ
    JACC Cardiovasc Interv; 2011 Mar; 4(3):298-9. PubMed ID: 21435607
    [No Abstract]   [Full Text] [Related]  

  • 39. A meta-analysis of randomized trials and adjusted observational studies of drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery disease.
    Takagi H; Umemoto T
    Int J Cardiol; 2011 Aug; 150(3):341-3. PubMed ID: 21636153
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravascular ultrasound optimization of drug-eluting stents: still not enough data.
    Leesar MA
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):584-5. PubMed ID: 20333656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.